http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020112253-A2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8ee0da6543d4d16f0634e75baf2d0d58 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-26 |
filingDate | 2019-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f9e2d765698514af1cc77dc52971695 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7a2e33ddffd9e13246ee4b559ea2b8d |
publicationDate | 2020-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-2020112253-A2 |
titleOfInvention | Uses of glucagon-like peptide-1 receptor agonists for treating trauma-induced hearing loss |
abstract | Methods of treating a subject for hearing loss or auditory impairment or damage, such as blast-induced hearing damage, comprising administering to the subject in need of such treatment an effective quantity of a glucagon-like peptide- 1 receptor (GLP-1R) agonist. The treatment may be given after exposure to a blast, loud noise, or other hearing loss-inducing traumatic event, or may be prophylactic, i.e., given prior to exposure to a blast or loud noise. |
priorityDate | 2018-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 81.